Assessment of the pattern and extent of arterial involvement and measurement of current
disease activity are essential for the management of Takayasu arteritis (TA). Since there is …

Takayasu arteritis (TA) is a rare large vessels vasculitis. Conventional therapy consists of
glucocorticoids which may be associated with other immunosuppressive drugs. However …

Objective: To assess the efficacy of anti-tumour necrosis factor (TNF) therapy to induce
remission in patients with Takayasu arteritis (TAK) refractory to other immunosuppressive …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 11th Annual Workshop on Advances in …

As in previous years, the consensus group to consider the use of biological agents was
constituted by rheumatologists from the universities of Erlangen, Leiden and Vienna in …

Abstract Takayasu's arteritis (TA), a rare large vessel vasculitis of unknown aetiology,
remains a difficult disease to manage with diagnosis often delayed until the late occlusive …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 13th Annual Workshop on Advances in …

Anti-TNF agents are recommended for the treatment of Takayasu's patients who are unable
to taper prednisone despite treatment with a nonbiologic immunosuppressive medication …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 10th Annual Workshop on Advances in …

OBJECTIVE: To retrospectively evaluate the clinical features, angiographic findings, and
outcomes of children with Takayasu arteritis (TA) in Turkey. METHODS: Clinical, laboratory …